• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I TOXO IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I TOXO IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII Back to Search Results
Catalog Number 07P45-32
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/10/2022
Event Type  malfunction  
Manufacturer Narrative
The evaluation of complaint data for the product and likely cause alinity i toxo igg reagent lot #: 35560be00 identified normal complaint activity and there are no trends for the product related to patient results.No customer returns were available for evaluation.Clinical specificity of the alinity i toxo igg assay has been evaluated with a retained in-house kit of the same lot #: 35560be00 and met all specifications confirming that this lot is meeting the alinity i toxo igg product requirements.A review of the manufacturing documentation did not identify any issues associated with the customers observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or product deficiency was identified for the alinity i toxo igg kit (lot #: 35560be00).Patient identifier complete sid: (b)(6).This report is being filed on an international product list number: 7p45-32 that has a similar product distributed in the us, list number: 7p45-45.
 
Event Description
The customer observed a false reactive alinity i toxo igg result, which was reported to be inconsistent with the patients history and questioned by the patients physician.The customer provided the following data: on (b)(6) 2022 result was < 0.20 iu/ml (non-reactive), on (b)(6) 2022 result was 17.60 iu/ml (reactive) (sample id provided: (b)(6)), on (b)(6) 2022 result was < 0.20 iu/ml (non-reactive).There was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TOXO IGG REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16021652
MDR Text Key308534550
Report Number3002809144-2022-00450
Device Sequence Number1
Product Code LGD
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K210596
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/16/2022
Device Catalogue Number07P45-32
Device Lot Number35560BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/02/2022
Initial Date FDA Received12/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/26/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI02377.
-
-